Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 27832143.
- Also identified by DOI 10.1371/journal.pone.0166036 and PMC identifier 5104464.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Higher vitamin D status was not beneficially associated with responses to therapy; if anything, patients with higher vitamin D concentrations were less likely to attain SVR. Our data do not support a role for vitamin D supplementation as an adjuvant therapy for HCV.
Medical subject headings
- Antiviral Agents
- Hepacivirus
- Hepatitis C, Chronic
- Interferon-alpha
- Ribavirin
- Vitamin D
- Vitamins